This list is based on the watchlists of people on Stock Events who follow 9RP.STU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Lipigon Pharmaceuticals AB (publ), a clinical-stage pharmaceutical company, develops drugs for lipid related diseases in Sweden. Its product pipeline consists of Lipisense project, which is in phase II for the treatment of severe hypertriglyceridemia disease; Dyslipidemia project, which is in preclinical trial to treat cardiovascular disease and severe hypertriglyceridemia; and CAP project, which is in preclinical trial to treat and prevent lung injury associated with community-acquired pneumonia. The company has a license agreement with Leaderna for the development of Lipisense. The company was incorporated in 2010 and is based in Umeå, Sweden.
What is Lipigon Pharmaceuticals AB stock price today?▼
The current price of 9RP.STU is €0 EUR — it has increased by +0% in the past 24 hours. Watch Lipigon Pharmaceuticals AB stock price performance more closely on the chart.
What is Lipigon Pharmaceuticals AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lipigon Pharmaceuticals AB stocks are traded under the ticker 9RP.STU.
Is Lipigon Pharmaceuticals AB stock price growing?▼
9RP.STU stock has risen by +0% compared to the previous week, the month change is a -50% fall, over the last year Lipigon Pharmaceuticals AB has showed a -96.87% decrease.
How many employees does Lipigon Pharmaceuticals AB have?▼
As of April 29, 2026, the company has 7 employees.
In which sector is Lipigon Pharmaceuticals AB located?▼
Lipigon Pharmaceuticals AB operates in the Health & Wellness sector.
When did Lipigon Pharmaceuticals AB complete a stock split?▼
Lipigon Pharmaceuticals AB has not had any recent stock splits.
Where is Lipigon Pharmaceuticals AB headquartered?▼
Lipigon Pharmaceuticals AB is headquartered in Umeå, Sweden.